The global hospital disinfection market is estimated to be valued at US$ 3.51 Billion in 2023 and is expected to exhibit a CAGR of 9.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:
Disinfectants are chemical solutions or detergents used to eliminate infectious agents or other harmful microorganisms from inanimate objects, surfaces or living tissues. They are widely used in hospitals to prevent the spread of infection during surgeries and patient care. Their use helps in reducing hospital acquired infections to a significant level.

Market key trends:
One of the key trends in the hospital disinfection market is the increased demand for environment-friendly disinfectants. Most of the conventionally used disinfectants contain toxic chemicals that produce harmful byproducts. However, growing environmental awareness is driving the demand for eco-friendly alternatives such as hydrogen peroxide disinfectants and citric acid-based disinfectants. Manufacturers are increasingly focusing on developing sustainable products that are non-toxic, non-caustic and have neutralizing characteristics to cause no harm.
SWOT Analysis
Strength: Hospital surgical disinfectants are used for sterilizing instruments and equipment to prevent surgical site infections. This ensures better patient outcomes and safety.
Weakness: Rigorous regulatory requirements and lengthy approval processes increase the costs and time required to bring new surgical disinfectants to the market.
Opportunity: Rising healthcare expenditure and increased focus on infection control in hospitals present an opportunity for companies to develop more effective and automated surgical disinfection solutions.
Threats: Stringent regulations and strict quality standards pose compliance challenges for manufacturers. Substitution threat from alternative infection control solutions.

Key Takeaways
The Hospital Surgical Disinfectants Market Growth is expected to witness high growth, exhibiting CAGR of 9.6% over the forecast period, due to increasing prevalence of hospital acquired infections.

Regional analysis: North America dominated the global market in 2023 and is expected to maintain its leading position during the forecast period. This is attributed to growing awareness about hospital acquired infections, implementation of guidelines regarding sterilization and disinfection, and rapid expansion of healthcare infrastructure in the US and Canada. Asia Pacific is projected to be the fastest growing regional market due to rising medical tourism, increasing healthcare spending, and growing demand for quality healthcare services.

Key players operating in the hospital surgical disinfectants market are 3M Company, Reckitt Benckiser Group plc, Ecolab Inc., Steris plc, Cardinal Health, Becton, Dickinson and Company, Kimberly-Clark Corporation, Bio-Cide International Inc., Shandong Weigao Group Medical Polymer Company Limited, Carenow Medical Pvt. Ltd., B.Braun Melsungen AG, HARTMANN GROUP, Merck KGaA, Entaco Ltd., Medalkan, Medichem S.A., Ruhof Healthcare, Clinicept Healthcare, Integra LifeSciences Holdings Corporation, Micro-Scientific, LLC.

 

Read More: https://businessinmyarea.com/latest/projected-rising-hospital-acquired-infections-to-boost-the-growth-of-hospital-surgical-disinfectants-market